GORMAN KEVIN CHARLES 4
4 · NEUROCRINE BIOSCIENCES INC · Filed May 22, 2025
Insider Transaction Report
Form 4
GORMAN KEVIN CHARLES
Director
Transactions
- Award
Non-Qualified Stock Option
2025-05-21+6,610→ 6,610 totalExercise: $120.56Exp: 2035-05-21→ Common Stock (6,610 underlying)
Footnotes (1)
- [F1]Option vests in 12 monthly installments beginning June 21, 2025.